Form EFFECT Clearmind Medicine Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 18, 2026 |
| Accession Number: | 0001213900-26-068893 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clearmind Medicine testifies at FDA psychedelic hearing in D.C.
- Vyzoxa, an EdTech Platform for AI Agent Development Learning, Empowers Learners Worldwide to Move From Using AI to Building With It, With a Mission to Shape One Million AI Innovators by 2030
- NatPat Announces DEET-Free Kids' BuzzPatch Bundles Amid Severe Mosquito Season
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
